5 Key Takeaways

• 1

  The FDA has authorized Essilor Stellest eyeglass lenses to correct nearsightedness and slow its progression in children.

• 2

  These lenses are designed for children aged 6 to 12, addressing pediatric myopia affecting about 40% of the US population.

• 3

  The Stellest lenses slowed myopia progression by 71% and reduced eye elongation by 53% compared to standard lenses.

• 4

  This authorization expands treatment options beyond contact lenses, which are limited to children ages 8 to 12.

• 5

  Untreated myopia can lead to serious complications, including retinal detachment, glaucoma, and cataracts.